Collaborative studies integrating clinical, molecular, and histopathological data will provide a more comprehensive understanding of visfatin’s role in tumor progression and treatment response, ultimately paving the way for more targeted and effective therapies in upper gastrointestinal cancers. Here, NAMPT is linked to neoplasm.